Reciprocal protection of Mcl-1 and Bim from ubiquitin-proteasome degradation

被引:27
作者
Wuilleme-Toumi, Soraya
Trichet, Valerie
Gomez-Bougie, Patricia
Gratas, Catherine
Bataille, Regis
Amiot, Martine
机构
[1] INSERM, Dept Rech Cancerol, UMR601, F-44000 Nantes, France
[2] Univ Nantes, Nantes Atlantique Univ, UFR Med & Tech Med, Nantes, France
[3] Natl Canc 2005, Equipe Labelisee Ligue 5, Nantes, France
[4] INSERM, ERI 7, Nantes, France
基金
澳大利亚研究理事会;
关键词
Mcl-1; bim; ubiquitination; RNA interference; multiple myeloma; Bcl-2 family proteins; short hairpin RNA; proteasome;
D O I
10.1016/j.bbrc.2007.07.070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survival of multiple myeloma cells is essentially dependent on Mcl-1 protein that neutralizes the pro-apoptotic function of Bim and prevents activation of death effectors. To clarify the relationship between Mcl-1 and Bim, we generated cell lines silenced for Mcl-1 (shMcl-1) or Bim (shBim). We demonstrate that Mcl-1 and Bim proteins are concomitantly down-regulated in either shBim or shMcl-1 cells. We show that the down-regulation of either Mcl-1 in shBim or Bim in hMcl-1 cells is not due to a transcriptional event, but results from post-translational regulation. Indeed, the multi-ubiquitinated forms of Mcl-1 or Bim are increased in shBim and shMcl-1 cells, respectively, indicating proteasome degradation. Since Mcl-1/Bim complexes are predominant in myeloma cells the down-regulation of Mcl-1 by shRNA leads to unliganded Bim sensitive to degradation and reciprocally for unliganded Mcl-1 in shBim cells. Finally, our results support that the interaction between McI-1 and Bim confers to themselves mutual protection. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:865 / 869
页数:5
相关论文
共 26 条
[1]   Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim [J].
Akiyama, T ;
Bouillet, P ;
Miyazaki, T ;
Kadono, Y ;
Chikuda, H ;
Chung, UG ;
Fukuda, A ;
Hikita, A ;
Seto, H ;
Okada, T ;
Inaba, T ;
Sanjay, A ;
Baron, R ;
Kawaguchi, H ;
Oda, H ;
Nakamura, K ;
Strasser, A ;
Tanaka, S .
EMBO JOURNAL, 2003, 22 (24) :6653-6664
[2]  
Bouillet P, 2000, ANN NY ACAD SCI, V926, P83
[3]   Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members [J].
Certo, Michael ;
Moore, Victoria Del Gaizo ;
Nishino, Mari ;
Wei, Guo ;
Korsmeyer, Stanley ;
Armstrong, Scott A. ;
Letai, Anthony .
CANCER CELL, 2006, 9 (05) :351-365
[4]   Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function [J].
Chen, L ;
Willis, SN ;
Wei, A ;
Smith, BJ ;
Fletcher, JI ;
Hinds, MG ;
Colman, PM ;
Day, CL ;
Adams, JM ;
Huang, DCS .
MOLECULAR CELL, 2005, 17 (03) :393-403
[5]   Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cells [J].
Clohessy, JG ;
Zhuang, JG ;
Brady, HJM .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (05) :655-665
[6]   DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells [J].
Cuconati, A ;
Mukherjee, C ;
Perez, D ;
White, E .
GENES & DEVELOPMENT, 2003, 17 (23) :2922-2932
[7]   Antisense strategy shows that Mcl-1 rather than Bcl-2 or BCI-xL is an essential survival protein of human myeloma cells [J].
Derenne, S ;
Monia, B ;
Dean, NM ;
Taylor, JK ;
Rapp, MJ ;
Harousseau, JL ;
Bataille, R ;
Amiot, M .
BLOOD, 2002, 100 (01) :194-199
[8]   Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1 [J].
Derouet, M ;
Thomas, L ;
Cross, A ;
Moots, RJ ;
Edwards, SW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :26915-26921
[9]   Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex [J].
Gomez-Bougie, P ;
Oliver, L ;
Le Gouill, S ;
Bataille, R ;
Amiot, M .
ONCOGENE, 2005, 24 (54) :8076-8079
[10]   The imbalance between Bim and Mcl-1 expression controls the survival of human myeloma cells [J].
Gomez-Bougie, P ;
Bataille, R ;
Amiot, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (11) :3156-3164